R&D SOS
New at Reason: Ron Bailey investigates how Medicare drug price controls would dry up money for pharmaceutical research and development.
New at Reason: Ron Bailey investigates how Medicare drug price controls would dry up money for pharmaceutical research and development.
Celebrate your independence with a subscription to Reason magazine, your most trusted source of honest, insightful news and analysis.